GlaxoSmithKline

News GlaxoSmithKline

• GlaxoSmithKline wins top prize at IChemE Awards

  GlaxoSmithKline clinched the top prize at the IChemE 2012 Awards in recognition of its radical change in the manufacture of pharmaceuticals. The organisation won the Outstanding Achievement in Chemical Engineering Award alongside project partners GEA, Siemens, Sagentia and the Universities of Newcas more

• AkzoNobel appoints new Decorative Paints Global Head of Marketing

  AkzoNobel has appointed Sucheta Govil as the new Global Head of Marketing for the company's Decorative Paints business. Based in Slough in the UK, she will officially take up the position on January 1. She joins AkzoNobel from PepsiCo., where her last role was as VP Innovations and New Business for more

• Science and industry in dialogue: The future of boron chemistry

  From June 15 – 16, the 6th international BASF Boron Conference took place in Ludwigshafen. As in the years before, more than 100 participants from industry and academia attended the meeting to discuss current trends and new applications of boron compounds in fine chemistry. The increasing importance more

Publications GlaxoSmithKline

• CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys

  A major goal in drug design is the improvement of computational methods for docking and scoring. The Community Structure Activity Resource (CSAR) has collected several data sets from industry and added in-house data sets that may be used for this purpose (www.csardock.org). CSAR has currently obtain more

• Synthesis of 5-(ethylsulfonyl)-2-methoxyaniline: An important pharmacological fragment of VEGFR2 and other inhibitors

  Abstract Background: 5-(Ethylsulfonyl)-2-methoxyaniline (5) is part of the structure in 131 compounds possessing different biological activities. In most cases, they have antitumor properties (112 compounds). Other compounds are described as cardiovascular agents, ion-channel blockers, nervous-sy more

• [News of the Week] Around the World

  In science news around the world this week, an Indian government advisory panel advocated wider acceptance of genetic engineering and biotechnology, a Japanese researcher's groundbreaking stem cell experiment has been questioned, a U.S. bioethics commission made recommendations for protecting patien more

Market studies GlaxoSmithKline

• India Pharmaceuticals and Healthcare Report Q1 2011

  Underpinned by relative political stability and driven by a booming economy, India's pharmaceuticalmarket is highly promising. Combined sales of prescription drugs and over-the-counter (OTC) medicinesare forecast to increase from INR739.3bn (US$15.65bn) in 2009 to INR837.7bn (US$18.05bn) in 2010.Due more

Websites GlaxoSmithKline